MY199800A - Genetic regulation of immunoresponse by chromosome interactions - Google Patents
Genetic regulation of immunoresponse by chromosome interactionsInfo
- Publication number
- MY199800A MY199800A MYPI2020002029A MYPI2020002029A MY199800A MY 199800 A MY199800 A MY 199800A MY PI2020002029 A MYPI2020002029 A MY PI2020002029A MY PI2020002029 A MYPI2020002029 A MY PI2020002029A MY 199800 A MY199800 A MY 199800A
- Authority
- MY
- Malaysia
- Prior art keywords
- immunoresponse
- genetic regulation
- chromosome interactions
- interactions
- chromosome
- Prior art date
Links
- 210000000349 chromosome Anatomy 0.000 title abstract 2
- 230000003993 interaction Effects 0.000 title abstract 2
- 230000004034 genetic regulation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762581287P | 2017-11-03 | 2017-11-03 | |
| GB2018052818 | 2018-10-03 | ||
| PCT/GB2018/053196 WO2019086898A2 (en) | 2017-11-03 | 2018-11-02 | Genetic regulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY199800A true MY199800A (en) | 2023-11-23 |
Family
ID=64661410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2020002029A MY199800A (en) | 2017-11-03 | 2018-11-02 | Genetic regulation of immunoresponse by chromosome interactions |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11840737B2 (enExample) |
| EP (1) | EP3704274B1 (enExample) |
| JP (2) | JP2021501592A (enExample) |
| KR (1) | KR102885025B1 (enExample) |
| CN (1) | CN111511930B (enExample) |
| AU (1) | AU2018361833B2 (enExample) |
| CA (1) | CA3078675A1 (enExample) |
| ES (1) | ES2987603T3 (enExample) |
| HU (1) | HUE066292T2 (enExample) |
| MY (1) | MY199800A (enExample) |
| PL (1) | PL3704274T3 (enExample) |
| SG (1) | SG11202003233YA (enExample) |
| WO (1) | WO2019086898A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3152645A1 (en) * | 2019-09-11 | 2021-03-18 | Oxford BioDynamics PLC | Diagnostic chromosome marker |
| EP4121964A1 (en) * | 2020-03-17 | 2023-01-25 | Regeneron Pharmaceuticals, Inc. | Methods and systems for determining responders to treatment |
| GB202008269D0 (en) * | 2020-06-02 | 2020-07-15 | Oxford Biodynamics Ltd | Detecting a chromosome marker |
| GB202016176D0 (en) * | 2020-10-12 | 2020-11-25 | Oxford BioDynamics PLC | Disease marker |
| TW202302862A (zh) * | 2021-03-04 | 2023-01-16 | 英商牛津生物力學公眾有限公司 | 染色體交互作用標記物 |
| WO2025215189A1 (en) * | 2024-04-12 | 2025-10-16 | Oxford BioDynamics PLC | Chromosome marker test |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR036993A1 (es) * | 2001-04-02 | 2004-10-20 | Wyeth Corp | Uso de agentes que modulan la interaccion entre pd-1 y sus ligandos en la submodulacion de respuestas inmunologicas |
| GB0603251D0 (en) | 2006-02-17 | 2006-03-29 | Isis Innovation | DNA conformation |
| AU2008204338B2 (en) | 2007-01-11 | 2014-03-06 | Erasmus University Medical Center | Circular chromosome conformation capture (4C) |
| WO2009051268A2 (en) | 2007-10-15 | 2009-04-23 | Takeda Pharmaceutical Company Limited | Preventive/remedy for cancer |
| GB0810051D0 (en) | 2008-06-02 | 2008-07-09 | Oxford Biodynamics Ltd | Method of diagnosis |
| BRPI1007093A2 (pt) | 2009-05-12 | 2017-06-06 | Koninl Philips Electronics Nv | fosfodiesterase 4d7 uso de pde4d7; composição metodo, metodo de aquisição de dados imunoensaio para detectar diagnosticar, monitorar ou prognosticar cancer de prostata ou para diagnosticar, detectar monitorar ou prognosticar progressao do cancer |
| EP3004877A4 (en) * | 2013-06-06 | 2017-04-19 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for identification, assessment prevention, and treatment of cancer using pd-l1 isoforms |
| WO2015077414A1 (en) | 2013-11-20 | 2015-05-28 | Dana-Farber Cancer Institute, Inc. | Kynurenine pathway biomarkers predictive of anti-immune checkpoint inhibitor response |
| JP2018518203A (ja) * | 2015-06-24 | 2018-07-12 | オックスフォード バイオダイナミックス リミテッド | エピジェネティックな染色体相互作用 |
-
2018
- 2018-11-02 HU HUE18815789A patent/HUE066292T2/hu unknown
- 2018-11-02 WO PCT/GB2018/053196 patent/WO2019086898A2/en not_active Ceased
- 2018-11-02 AU AU2018361833A patent/AU2018361833B2/en active Active
- 2018-11-02 US US16/760,541 patent/US11840737B2/en active Active
- 2018-11-02 CA CA3078675A patent/CA3078675A1/en active Pending
- 2018-11-02 KR KR1020207012736A patent/KR102885025B1/ko active Active
- 2018-11-02 ES ES18815789T patent/ES2987603T3/es active Active
- 2018-11-02 CN CN201880083380.6A patent/CN111511930B/zh active Active
- 2018-11-02 EP EP18815789.5A patent/EP3704274B1/en active Active
- 2018-11-02 MY MYPI2020002029A patent/MY199800A/en unknown
- 2018-11-02 JP JP2020524490A patent/JP2021501592A/ja active Pending
- 2018-11-02 PL PL18815789.5T patent/PL3704274T3/pl unknown
- 2018-11-02 SG SG11202003233YA patent/SG11202003233YA/en unknown
-
2023
- 2023-04-03 JP JP2023060384A patent/JP7631400B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3078675A1 (en) | 2019-05-09 |
| AU2018361833A1 (en) | 2020-04-30 |
| AU2018361833B2 (en) | 2021-04-22 |
| EP3704274A2 (en) | 2020-09-09 |
| ES2987603T3 (es) | 2024-11-15 |
| SG11202003233YA (en) | 2020-05-28 |
| HUE066292T2 (hu) | 2024-07-28 |
| US20210230702A1 (en) | 2021-07-29 |
| EP3704274C0 (en) | 2024-04-17 |
| US11840737B2 (en) | 2023-12-12 |
| KR20200081380A (ko) | 2020-07-07 |
| JP2023082157A (ja) | 2023-06-13 |
| PL3704274T3 (pl) | 2024-07-08 |
| NZ763540A (en) | 2025-03-28 |
| KR102885025B1 (ko) | 2025-11-11 |
| WO2019086898A3 (en) | 2019-06-13 |
| WO2019086898A2 (en) | 2019-05-09 |
| JP2021501592A (ja) | 2021-01-21 |
| CN111511930B (zh) | 2024-11-22 |
| JP7631400B2 (ja) | 2025-02-18 |
| CN111511930A (zh) | 2020-08-07 |
| EP3704274B1 (en) | 2024-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY199800A (en) | Genetic regulation of immunoresponse by chromosome interactions | |
| IL284796B (en) | Control of gene expression through aptamer-mediated modulation of alternative splicing | |
| IL287033A (en) | Regulation of nuclease-mediated gene expression | |
| MY186113A (en) | Epigenetic chromosome interactions | |
| GR20140100479A (el) | Συνθεση λιραγλουτιδης | |
| MX2017010638A (es) | Derivados de sobetiroma. | |
| EP3332014A4 (en) | METHOD FOR PRODUCING ANIMAL WITH GENETIC GLAND CARBON MODIFICATION | |
| AU2014375265A1 (en) | Novel pyrazolyl-heteroarylamides as pesticides | |
| MX2020001278A (es) | Sintesis de compuestos de carbamoilpiridona policiclica. | |
| MY195357A (en) | Detection of Chromosome Interaction Relevant to Breast Cancer | |
| ECSDI17072111S (es) | Recipiente contenedor (iv) | |
| MX2016014765A (es) | Incremento del rendimiento utilizando soforolipidos. | |
| IL268977A (en) | Regulation of gene expression by aptamer-modulated rnase p cleavage | |
| EP3463723A4 (en) | SYNTHESIS OF ULTRA-THIN METAL NANOWIRES WITH ORGANIC FREE RADICALS | |
| EA201691426A1 (ru) | Регулирование метаболизма орнитина для управления содержанием высокоманнозных гликоформ рекомбинантных белков | |
| MY200184A (en) | Biomarker | |
| DK3625327T3 (da) | Højproduktive fremgangsmåder til methanfermentering | |
| PH12017500499A1 (en) | Synthesis of ent-progesterone and intermediates thereof | |
| DK201300088U1 (da) | Et produkt med nyttige egenskaber | |
| HK40079456B (zh) | 通过对选择性剪接进行适体介导的调节来实现的基因表达调控 | |
| DK201300195U1 (da) | Et produkt med nyttige egenskaber Et produkt med nyttige egenskaber | |
| IN2014MU00171A (enExample) | ||
| TH1501004767A (th) | การดัดแปรพันธุกรรมของหนูแรท(genetic modification of rats) | |
| TH1601000684B (th) | ชุดเครื่องควบคุมสำหรับตัวปรับความดันแก๊ส |